Literature DB >> 26242166

[PERSONALIZATION OF TREATMENT FOR CERVICAL CANCER DURING PREGNANCY].

E A Ulrikh, I V Berlev, A F Urmancheeva, E A Verbitskaya, N A Mikaya, A V Mikhailov, A B Iliin, Z N Gamzatova, Yu V Yankevich, A S Artemieval, E N Korolkova.   

Abstract

The paper presents a clinical case of a patient of 29 years old with a diagnosis of cervical cancer sIIA1 stage with the modern therapeutic approach: as a diagnostic and treatment phase there was performed videoendoscopic pelvic lymph node dissection at a 16-week pregnancy, excluded lymphogenous spread of tumor and on the basis of which it was decided to prolong pregnancy, given the strong desire of the patient to keep the baby. At a 19-week and a 23-week pregnancy there were two courses of neoadjuvant chemotherapy and at a 34-week--Cesarean delivery with simultaneous radical hysterectomy and ovarian transposition followed by a course of adjuvant distant radiotherapy. The final diagnosis was as pT2aN0M0. The observation was during 7 months: the patient is alive without recurrence, the child develops without physical and psychomotor abnormalities.

Entities:  

Mesh:

Year:  2015        PMID: 26242166

Source DB:  PubMed          Journal:  Vopr Onkol        ISSN: 0507-3758


  2 in total

Review 1.  Personalized treatment of malignant tumors during pregnancy.

Authors:  E Ulrikh; E Kalinina; E Dikareva; E Komlichenko; O Li; O Zhamborova; I Rizhinashvili; A Dzharbaeva; I Govorov; V Artemenko; V Bezrukikh; G Salogub; T Pervunina; A Urmancheeva
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

Review 2.  Clinical Use of Progestins and Their Mechanisms of Action: Present and Future (Review).

Authors:  T A Fedotcheva
Journal:  Sovrem Tekhnologii Med       Date:  2021-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.